AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H1693-H1698, 2006. First published December 3, 2005; doi:10.1152/ajpheart.00947.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/H1693    most recent
00947.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luksch, A.
Right arrow Articles by Schmetterer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luksch, A.
Right arrow Articles by Schmetterer, L.

ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise

Alexandra Luksch,1,2 Barbara Wimpissinger,1 Kaija Polak,2 Kerstin Jandrasits,2 and Leopold Schmetterer1,3

1Departments of Clinical Pharmacology, 2Ophthalmology and Optometry, and 3Biomedical Engineering and Physics, University of Vienna, Vienna, Austria

Submitted 6 September 2005 ; accepted in final form 11 November 2005

Angiotensin II and endothelin-1 are potent vasoconstrictors that appear to play a role in retinal blood flow regulation. In the present study, we investigated the possible role of the angiotensin and the endothelin system in the regulation of retinal vessel diameters during isometric exercise in healthy humans. The study design was randomized, double-masked, placebo-controlled, and three-way cross over. Twelve healthy subjects performed squatting exercises for 6 min during infusion of either an angiotensin-converting enzyme inhibitor (enalapril), an ETA-receptor antagonist (BQ-123), or placebo. Retinal vessel diameters were measured continuously with the Zeiss retinal vessel analyzer. Systemic hemodynamics were assessed noninvasively, and intraocular pressure was measured with applanation tonometry. Squatting induced a significant increase in blood pressure and pulse rate, which was paralleled by a vasoconstriction in retinal arteries and veins. Intraocular pressure was only slightly increased during the squatting periods. BQ-123 significantly blunted the exercise-induced decrease in venous (P < 0.01) and arterial (P < 0.02, ANOVA) vessel diameters but had no effect on basal retinal diameters. By contrast, enalapril did neither influence vessel diameter at baseline conditions nor in response to isometric exercise. The data of the present study indicate that retinal vasoconstriction during isometric exercise is modified by ETA-receptor blockade, whereas it is not altered by angiotensin-converting enzyme inhibition. Hence, the present data indicate that endothelin-1, but not angiotensin II, is involved in retinal blood flow regulation during isometric exercise.

retinal blood flow autoregulation; isometric exercise; human



Address for reprint requests and other correspondence: L. Schmetterer, Dept. of Clinical Pharmacology, Währinger Gürtel 18–20, University of Vienna, A-1090 Vienna, Austria (e-mail: leopold.schmetterer{at}meduniwien.ac.at)




This article has been cited by other articles:


Home page
IOVSHome page
T. W. Hein, Y. Ren, Z. Yuan, W. Xu, S. Somvanshi, T. Nagaoka, A. Yoshida, and L. Kuo
Functional and Molecular Characterization of the Endothelin System in Retinal Arterioles
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3329 - 3336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.